long-acting endostatin (Bolder BioTechnology)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug Namelong-acting endostatin (Bolder BioTechnology)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionAngiogenesis inhibitors
TargetsUpdating
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending
Highest Status in ChinaN/A
Originator CompaniesBolder Biotechnology
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBolder Biotechnology
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A